Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235) 1

By Kucuk O.   Fisher E.   Moinpour C.M.   Coleman D.   Hussain M.H.A.   Sartor A.O.   Chatta G.S.   Lowe B.A.   Eisenberger M.A.   Crawford E.D.  

Urology, Vol. 58, Iss. 1, 2001-07 ,pp. : 53-58

Elsevier

Access to resources Recommend Favorite

A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as second-line treatment for advanced colorectal cancer: A Japanese experience

By Ogata Yutaka  

Surgery Today, Vol. 41, Iss. 1, 2011-01 ,pp. : 84-90

Springer Publishing Company

Access to resources Recommend Favorite

Nilutamide: possible utility as a second-line hormonal agent

By Desai A.   Stadler W.M.   Vogelzang N.J.  

Urology, Vol. 58, Iss. 6, 2001-12 ,pp. : 1016-1020

Elsevier

Access to resources Recommend Favorite

A phase II trial of oral estramustine and oral etoposide in hormone refractory prostate cancer

By Pienta K.J.   Redman B.G.   Bandekar R.   Strawderman M.   Cease K.   Esper P.S.   Naik H.   Smith D.C.  

Urology, Vol. 50, Iss. 3, 1997-09 ,pp. : 401-407

Elsevier

Access to resources Recommend Favorite

Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer

By Clark P.E.   Peereboom D.M.   Dreicer R.   Levin H.S.   Clark S.B.   Klein E.A.  

Urology, Vol. 57, Iss. 2, 2001-02 ,pp. : 281-285

Elsevier

Access to resources Recommend Favorite